Advertisement

Journal of NeuroVirology

, Volume 18, Issue 6, pp 511–520 | Cite as

Mitochondrial DNA variation and HIV-associated sensory neuropathy in CHARTER

  • Emily R. Holzinger
  • Todd Hulgan
  • Ronald J. Ellis
  • David C. Samuels
  • Marylyn D. Ritchie
  • David W. Haas
  • Asha R. Kallianpur
  • Cinnamon S. Bloss
  • David B. Clifford
  • Ann C. Collier
  • Benjamin B. Gelman
  • Christina M. Marra
  • Justin C. McArthur
  • J. Allen McCutchan
  • Susan Morgello
  • David M. Simpson
  • Donald R. Franklin
  • Debralee Rosario
  • Doug Selph
  • Scott Letendre
  • Igor Grant
  • for the CHARTER Group
Article

Abstract

HIV-associated sensory neuropathy remains an important complication of combination antiretroviral therapy and HIV infection. Mitochondrial DNA haplogroups and single nucleotide polymorphisms (SNPs) have previously been associated with symptomatic neuropathy in clinical trial participants. We examined associations between mitochondrial DNA variation and HIV-associated sensory neuropathy in CNS HIV Antiretroviral Therapy Effects Research (CHARTER). CHARTER is a USA-based longitudinal observational study of HIV-infected adults who underwent a structured interview and standardized examination. HIV-associated sensory neuropathy was determined by trained examiners as ≥1 sign (diminished vibratory and sharp–dull discrimination or ankle reflexes) bilaterally. Mitochondrial DNA sequencing was performed and haplogroups were assigned by published algorithms. Multivariable logistic regression of associations between mitochondrial DNA SNPs, haplogroups, and HIV-associated sensory neuropathy were performed. In analyses of associations of each mitochondrial DNA SNP with HIV-associated sensory neuropathy, the two most significant SNPs were at positions A12810G [odds ratio (95 % confidence interval) = 0.27 (0.11–0.65); p = 0.004] and T489C [odds ratio (95 % confidence interval) = 0.41 (0.21–0.80); p = 0.009]. These synonymous changes are known to define African haplogroup L1c and European haplogroup J, respectively. Both haplogroups were associated with decreased prevalence of HIV-associated sensory neuropathy compared with all other haplogroups [odds ratio (95 % confidence interval) = 0.29 (0.12–0.71); p = 0.007 and odds ratio (95 % confidence interval) = 0.42 (0.18–1.0); p = 0.05, respectively]. In conclusion, in this cohort of mostly combination antiretroviral therapy-treated subjects, two common mitochondrial DNA SNPs and their corresponding haplogroups were associated with a markedly decreased prevalence of HIV-associated sensory neuropathy.

Keywords

Genetics Mitochondria HIV-related neurological diseases Peripheral neuropathy 

Notes

Acknowledgments

The CNS HIV Antiretroviral Therapy Effects Research (CHARTER) group is affiliated with the Johns Hopkins University; Mount Sinai School of Medicine; University of California, San Diego; University of Texas, Galveston; University of Washington, Seattle; and Washington University, St. Louis and is headquartered at the University of California, San Diego and includes Director: Igor Grant, M.D.; Co-Directors: Scott L. Letendre, M.D., Ronald J. Ellis, M.D., Ph.D., Thomas D. Marcotte, Ph.D.; Center Manager: Donald Franklin, Jr.; Neuromedical Component: Ronald J. Ellis, M.D., Ph.D. (P.I.), J. Allen McCutchan, M.D., Terry Alexander, R.N.; Laboratory, Pharmacology and Immunology Component: Scott Letendre, M.D. (P.I.), Edmund Capparelli, Pharm.D.; Neurobehavioral Component: Robert K. Heaton, Ph.D. (P.I.), J. Hampton Atkinson, M.D., Steven Paul Woods, Psy.D., Matthew Dawson; Virology Component: Davey M. Smith, M.D. (P.I.), Joseph K. Wong, M.D.; Imaging Component: Christine Fennema-Notestine, Ph.D. (Co-P.I.), Michael J. Taylor, Ph.D. (Co-P.I.), Rebecca Theilmann, Ph.D.; Data Management Component: Anthony C. Gamst, Ph.D. (P.I.), Clint Cushman; Statistics Component: Ian Abramson, Ph.D. (P.I.), Florin Vaida, Ph.D.; Johns Hopkins University site: Justin McArthur (P.I.), Mary Smith; Mount Sinai School of Medicine site: Susan Morgello, M.D. (Co-P.I.) and David Simpson, M.D. (Co-P.I.), Letty Mintz, N.P.; University of California, San Diego site: J. Allen McCutchan, M.D. (P.I.), Will Toperoff, N.P.; University of Washington, Seattle site: Ann Collier, M.D. (Co-P.I.) and Christina Marra, M.D. (Co-P.I.), Trudy Jones, M.N., A.R.N.P.; University of Texas, Galveston site: Benjamin Gelman, M.D., Ph.D. (P.I.), Eleanor Head, R.N., B.S.N.; and Washington University, St. Louis site: David Clifford, M.D. (P.I.), Muhammad Al-Lozi, M.D., Mengesha Teshome, M.D.

Conflict of interest

The views expressed in this article are those of the authors and do not reflect the official policy or position of the United States Government.

Funding

The CNS HIV Antiretroviral Therapy Effects Research study is supported by awards (N01 MH22005, HHSN271201000027C, and HHSN271201000030C) from the National Institutes of Health.

References

  1. Andrews RS, Kubacka I, Chinnery PF, Lightowlers RN, Turnbull DM, Howell N (1999) Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat Genet 23:147Google Scholar
  2. Brinkman K, Smeitink JA, Romijn JA, Reiss P (1999) Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy. Lancet 354:1112–1115PubMedCrossRefGoogle Scholar
  3. Brown MD, Sun F, Wallace DC (1997) Clustering of Caucasian Leber hereditary optic neuropathy patients containing the 11778 or 14484 mutations on an mtDNA lineage. Am J Hum Genet 60:381–387PubMedCrossRefGoogle Scholar
  4. Brown MD, Starikovskaya E, Derbeneva O, Hosseini S, Allen JC, Mikhailovskaya IE, Sukernik RI, Wallace DC (2002) The role of mtDNA background in disease expression: a new primary LHON mutation associated with Western Eurasian haplogroup J. Hum Genet 110:130–138PubMedCrossRefGoogle Scholar
  5. Canter JA, Kallianpur AR, Parl FF, Millikan RC (2005) Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women. Cancer Res 65:8028–8033PubMedGoogle Scholar
  6. Canter JA, Robbins GK, Selph D, Clifford DB, Kallianpur AR, Shafer R, Levy S, Murdock DG, Ritchie MD, Haas DW, Hulgan T (2010) African mitochondrial DNA subhaplogroups and peripheral neuropathy during antiretroviral therapy. J Infect Dis 201:1703–1707PubMedCrossRefGoogle Scholar
  7. Cherry CL, Rosenow A, Affandi JS, McArthur Justin C, Wesselingh SL, Price P (2008) Cytokine genotype suggests a role for inflammation in nucleoside analog-associated sensory neuropathy (NRTI-SN) and predicts an individual’s NRTI-SN risk. AIDS Res Hum Retroviruses 24:117–123PubMedCrossRefGoogle Scholar
  8. Dalakas MC, Semino-Mora C, Leon-Monzon M (2001) Mitochondrial alterations with mitochondrial DNA depletion in the nerves of AIDS patients with peripheral neuropathy induced by 2′3′-dideoxycytidine (ddC). Lab Invest 81:1537–1544PubMedCrossRefGoogle Scholar
  9. Datta S, Majumder M, Biswas NK, Sikdar N, Roy B (2007) Increased risk of oral cancer in relation to common Indian mitochondrial polymorphisms and autosomal GSTP1 locus. Cancer 110:1991–1999PubMedCrossRefGoogle Scholar
  10. DeBenedictis G, Rose G, Carrieri G, De LM, Falcone E, Passarino G, Bonafe M, Monti D, Baggio G, Bertolini S, Mari D, Mattace R, Franceschi C (1999) Mitochondrial DNA inherited variants are associated with successful aging and longevity in humans. FASEB J 13:1532–1536Google Scholar
  11. DiDonato S (2009) Multisystem manifestations of mitochondrial disorders. J Neurol 256:693–710CrossRefGoogle Scholar
  12. Ellis R (2010) HIV and antiretroviral therapy: impact on the central nervous system. Prog Neurobiol 2009(10/28):185–187CrossRefGoogle Scholar
  13. Ellis RJ, Rosario D, Clifford DB, McArthur JC, Simpson D, Alexander T, Gelman BB, Vaida F, Collier A, Marra CM, Ances B, Atkinson JH, Dworkin RH, Morgello S, Grant I (2010) Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER study. Arch Neurol 67:552–558PubMedCrossRefGoogle Scholar
  14. Gomez-Duran A, Pacheu-Grau D, Lopez-Gallardo E, Diez-Sanchez C, Montoya J, Lopez-Perez MJ, Ruiz-Pesini E (2010) Unmasking the causes of multifactorial disorders: OXPHOS differences between mitochondrial haplogroups. Hum Mol Genet 2010(06/23):3343–3353CrossRefGoogle Scholar
  15. Grady BJ, Torstenson E, Dudek SM, Giles J, Sexton D, Ritchie MD (2010). Finding unique filter sets in PLATO: a precursor to efficient interaction analysis in GWAS data. Pac Symp Biocomput: 315–326.Google Scholar
  16. Hendrickson SL, Hutcheson HB, Ruiz-Pesini E, Poole JC, Lautenberger J, Sezgin E, Kingsley L, Goedert JJ, Vlahov D, Donfield S, Wallace DC, O’Brien SJ (2008) Mitochondrial DNA haplogroups influence AIDS progression. AIDS 22:2429–2439PubMedCrossRefGoogle Scholar
  17. Hendrickson SL, Kingsley LA, Ruiz-Pesini E, Poole JC, Jacobson LP, Palella FJ, Bream JH, Wallace DC, O’Brien SJ (2009) Mitochondrial DNA haplogroups influence lipoatrophy after highly active antiretroviral therapy. J Acquir Immune Defic Syndr 51:111–116PubMedCrossRefGoogle Scholar
  18. Hendrickson SL, Jabs DA, Van NM, Lewis RA, Wallace DC, O’Brien SJ (2010) Mitochondrial haplogroups are associated with risk of neuroretinal disorder in HIV-positive patients. J Acquir Immune Defic Syndr 53:451–455PubMedCrossRefGoogle Scholar
  19. Herrnstadt C, Elson JL, Fahy E, Preston G, Turnbull DM, Anderson C, Ghosh SS, Olefsky JM, Beal MF, Davis RE, Howell N (2002) Reduced-median-network analysis of complete mitochondrial DNA coding-region sequences for the major African, Asian, and European haplogroups. Am J Hum Genet 70:1152–1171PubMedCrossRefGoogle Scholar
  20. Hulgan T, Haas DW, Haines JL, Ritchie MD, Robbins GK, Shafer RW, Clifford DB, Kallianpur AR, Summar M, Canter JA (2005) Mitochondrial haplogroups and peripheral neuropathy during antiretroviral therapy: an adult AIDS clinical trials group study. AIDS 19:1341–1349PubMedCrossRefGoogle Scholar
  21. Hulgan T, Tebas P, Canter JA, Mulligan K, Haas DW, Dube M, Grinspoon S, Robbins GK, Motsinger AA, Kallianpur AR (2008) Hemochromatosis gene polymorphisms, mitochondrial haplogroups, and peripheral lipoatrophy during antiretroviral therapy. J Infect Dis 197:858–866PubMedCrossRefGoogle Scholar
  22. Hulgan T, Haubrich R, Riddler SA, Tebas P, Ritchie MD, McComsey GA, Haas DW, Canter JA (2011) European mitochondrial DNA haplogroups and metabolic changes during antiretroviral therapy in AIDS Clinical Trials Group Study A5142. AIDS 25:37–47PubMedCrossRefGoogle Scholar
  23. Jones MM, Manwaring N, Wang JJ, Rochtchina E, Mitchell P, Sue CM (2007) Mitochondrial DNA haplogroups and age-related maculopathy. Arch Ophthalmol 125:1235–1240PubMedCrossRefGoogle Scholar
  24. Juo SH, Lu MY, Bai RK, Liao YC, Trieu RB, Yu ML, Wong LJ (2010) A common mitochondrial polymorphism 10398A > G is associated metabolic syndrome in a Chinese population. Mitochondrion 10:294–299PubMedCrossRefGoogle Scholar
  25. Kallianpur AR, Hulgan T, Canter JA, Ritchie MD, Haines JL, Robbins GK, Shafer RW, Clifford DB, Haas DW (2006) Hemochromatosis (HFE) gene mutations and peripheral neuropathy during antiretroviral therapy. AIDS 20:1503–1513PubMedCrossRefGoogle Scholar
  26. Kalman B, Li S, Chatterjee D, O’Connor J, Voehl MR, Brown MD, Alder H (1999) Large scale screening of the mitochondrial DNA reveals no pathogenic mutations but a haplotype associated with multiple sclerosis in Caucasians. Acta Neurol Scand 99:16–25PubMedCrossRefGoogle Scholar
  27. Kazuno AA, Munakata K, Nagai T, Shimozono S, Tanaka M, Yoneda M, Kato N, Miyawaki A, Kato T (2006) Identification of mitochondrial DNA polymorphisms that alter mitochondrial matrix pH and intracellular calcium dynamics. PLoS Genet 2:e128PubMedCrossRefGoogle Scholar
  28. Lehmann HC, Chen W, Borzan J, Mankowski JL, Hoke A (2011) Mitochondrial dysfunction in distal axons contributes to human immunodeficiency virus sensory neuropathy. Ann Neurol 2011(02/01):100–110CrossRefGoogle Scholar
  29. Mehta P, Mellick GD, Rowe DB, Halliday GM, Jones MM, Manwaring N, Vandebona H, Silburn PA, Wang JJ, Mitchell P, Sue CM (2009) Mitochondrial DNA haplogroups J and K are not protective for Parkinson’s disease in the Australian community. Mov Disord 24:290–292PubMedCrossRefGoogle Scholar
  30. Niemi AK, Hervonen A, Hurme M, Karhunen PJ, Jylha M, Majamaa K (2003) Mitochondrial DNA polymorphisms associated with longevity in a Finnish population. Hum Genet 112:29–33PubMedCrossRefGoogle Scholar
  31. Niemi AK, Moilanen JS, Tanaka M, Hervonen A, Hurme M, Lehtimaki T, Arai Y, Hirose N, Majamaa K (2005) A combination of three common inherited mitochondrial DNA polymorphisms promotes longevity in Finnish and Japanese subjects. Eur J Hum Genet 13:166–170PubMedCrossRefGoogle Scholar
  32. Pezzotti A, Kraft P, Hankinson SE, Hunter DJ, Buring J, Cox DG (2009) The mitochondrial A10398G polymorphism, interaction with alcohol consumption, and breast cancer risk. PLoS One 4:e5356PubMedCrossRefGoogle Scholar
  33. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559–575PubMedCrossRefGoogle Scholar
  34. Rai E, Sharma S, Koul A, Bhat AK, Bhanwer AJ, Bamezai RN (2007) Interaction between the UCP2-866G/A, mtDNA 10398G/A and PGC1alpha p.Thr394Thr and p.Gly482Ser polymorphisms in type 2 diabetes susceptibility in North Indian population. Hum Genet 122:535–540PubMedCrossRefGoogle Scholar
  35. Reynier P, Penisson-Besnier I, Moreau C, Savagner F, Vielle B, Emile J, Dubas F, Malthiery Y (1999) mtDNA haplogroup J: a contributing factor of optic neuritis. Eur J Hum Genet 7:404–406PubMedCrossRefGoogle Scholar
  36. Robinson-Papp J, Morgello S, Vaida F, Fitzsimons C, Simpson DM, Elliott KJ, Al-Lozi M, Gelman BB, Clifford D, Marra CM, McCutchan JA, Atkinson JH, Dworkin RH, Grant I, Ellis R (2010) Association of self-reported painful symptoms with clinical and neurophysiologic signs in HIV-associated sensory neuropathy. Pain 151:732–736PubMedCrossRefGoogle Scholar
  37. Ross OA, McCormack R, Maxwell LD, Duguid RA, Quinn DJ, Barnett YA, Rea IM, El-Agnaf OM, Gibson JM, Wallace A, Middleton D, Curran MD (2003) mt4216C variant in linkage with the mtDNA TJ cluster may confer a susceptibility to mitochondrial dysfunction resulting in an increased risk of Parkinson’s disease in the Irish. Exp Gerontol 38:397–405PubMedCrossRefGoogle Scholar
  38. Ruiz-Pesini E, Lott MT, Procaccio V, Poole JC, Brandon MC, Mishmar D, Yi C, Kreuziger J, Baldi P, Wallace DC (2007) An enhanced MITOMAP with a global mtDNA mutational phylogeny. Nucleic Acids Res 35:D823–D828PubMedCrossRefGoogle Scholar
  39. Sacktor N (2002) The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J Neurovirol 8(Suppl 2):115–121PubMedCrossRefGoogle Scholar
  40. Shafa Shariat PM, Houshmand M, Tabassi AR (2006) Mitochondrial D-loop variation in Leber hereditary neuropathy patients harboring primary G11778A, G3460A, T14484C mutations: J and W haplogroups as high-risk factors. Arch Med Res 37:1028–1033CrossRefGoogle Scholar
  41. Shlush LI, Atzmon G, Weisshof R, Behar D, Yudkovsky G, Barzilai N, Skorecki K (2008) Ashkenazi Jewish centenarians do not demonstrate enrichment in mitochondrial haplogroup. J PLoS One 3:e3425CrossRefGoogle Scholar
  42. Torroni A, Petrozzi M, D’Urbano L, Sellitto D, Zeviani M, Carrara F, Carducci C, Leuzzi V, Carelli V, Barboni P, De NA, Scozzari R (1997) Haplotype and phylogenetic analyses suggest that one European-specific mtDNA background plays a role in the expression of Leber hereditary optic neuropathy by increasing the penetrance of the primary mutations 11778 and 14484. Am J Hum Genet 60:1107–1121PubMedGoogle Scholar
  43. Van Der Walt JM, Nicodemus KK, Martin ER, Scott WK, Nance MA, Watts RL, Hubble JP, Haines JL, Koller WC, Lyons K, Pahwa R, Stern MB, Colcher A, Hiner BC, Jankovic J, Ondo WG, Allen FH, Goetz CG, Small GW, Mastaglia F, Stajich JM, McLaurin AC, Middleton LT, Scott BL, Schmechel DE, Pericak-Vance MA, Vance JM (2003) Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am J Hum Genet 72:804–811PubMedCrossRefGoogle Scholar
  44. Venkateswaran S, Zheng K, Sacchetti M, Gagne D, Arnold DL, Sadovnick AD, Scherer SW, Banwell B, Bar-Or A, Simon DK (2011) Mitochondrial DNA haplogroups and mutations in children with acquired central demyelination. Neurology 76:774–780PubMedCrossRefGoogle Scholar
  45. Verma S, Estanislao L, Mintz L, Simpson D (2004) Controlling neuropathic pain in HIV. Curr HIV/AIDS Rep 2005(08/11):136–141CrossRefGoogle Scholar
  46. Wallace DC (2005) A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 2005(11/16):359–407CrossRefGoogle Scholar
  47. Wallace DC, Brown MD, Lott MT (1999) Mitochondrial DNA variation in human evolution and disease. Gene 238:211–230PubMedCrossRefGoogle Scholar

Copyright information

© Journal of NeuroVirology, Inc. 2012

Authors and Affiliations

  • Emily R. Holzinger
    • 1
  • Todd Hulgan
    • 1
  • Ronald J. Ellis
    • 2
  • David C. Samuels
    • 1
  • Marylyn D. Ritchie
    • 3
  • David W. Haas
    • 1
  • Asha R. Kallianpur
    • 1
  • Cinnamon S. Bloss
    • 4
  • David B. Clifford
    • 5
  • Ann C. Collier
    • 6
  • Benjamin B. Gelman
    • 7
  • Christina M. Marra
    • 6
  • Justin C. McArthur
    • 8
  • J. Allen McCutchan
    • 2
  • Susan Morgello
    • 9
  • David M. Simpson
    • 9
  • Donald R. Franklin
    • 2
  • Debralee Rosario
    • 2
  • Doug Selph
    • 1
  • Scott Letendre
    • 2
  • Igor Grant
    • 2
  • for the CHARTER Group
  1. 1.Vanderbilt UniversityNashvilleUSA
  2. 2.University of California-San DiegoSan DiegoUSA
  3. 3.The Pennsylvania State UniversityUniversity ParkUSA
  4. 4.Scripps Research InstituteLa JollaUSA
  5. 5.Washington UniversitySt. LouisUSA
  6. 6.University of WashingtonSeattleUSA
  7. 7.University of Texas Medical BranchGalvestonUSA
  8. 8.Johns Hopkins UniversityBaltimoreUSA
  9. 9.Mount Sinai School of MedicineNew YorkUSA

Personalised recommendations